|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2001-3-20
|
|
pubmed:abstractText |
A major problem encountered during oral cyclosporin-A (CsA) administration to prevent acute graft-versus-host-disease (GVHD) after allogeneic bone marrow transplantation (allo-BMT) is its irregular pharmacokinetics. The aim of this study was to evaluate the pharmacokinetics of Neoral, a new water-free microemulsion formulation of CsA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
311-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11255279-Adult,
pubmed-meshheading:11255279-Aged,
pubmed-meshheading:11255279-Area Under Curve,
pubmed-meshheading:11255279-Bone Marrow Transplantation,
pubmed-meshheading:11255279-Cyclosporine,
pubmed-meshheading:11255279-Female,
pubmed-meshheading:11255279-Graft vs Host Disease,
pubmed-meshheading:11255279-Hematologic Neoplasms,
pubmed-meshheading:11255279-Humans,
pubmed-meshheading:11255279-Immunosuppressive Agents,
pubmed-meshheading:11255279-Male,
pubmed-meshheading:11255279-Middle Aged,
pubmed-meshheading:11255279-Transplantation, Homologous
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Pharmacokinetic study of the new cyclosporine-A formulation (Neoral) in adult allogeneic bone marrow transplant recipients.
|
|
pubmed:affiliation |
Divisione di Ematologia, Ospedali Riuniti di Bergamo, and Istituto di Ricerche Farmacologiche Mario Negri Bergamo, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
